American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the …

D Saslow, D Solomon, HW Lawson… - American journal of …, 2012 - academic.oup.com
An update to the American Cancer Society (ACS) guideline regarding screening for the early
detection of cervical precancerous lesions and cancer is presented. The guidelines are …

Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer

M Arbyn, G Ronco, A Anttila, CJLM Meijer, M Poljak… - Vaccine, 2012 - Elsevier
More than ever, clinicians need regularly updated reviews given the continuously increasing
amount of new information regarding innovative cervical cancer prevention methods. A …

Cytology versus HPV testing for cervical cancer screening in the general population

G Koliopoulos, VN Nyaga, N Santesso… - Cochrane database …, 2017 - cochranelibrary.com
Background Cervical cancer screening has traditionally been based on cervical cytology.
Given the aetiological relationship between human papillomavirus (HPV) infection and …

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

G Ronco, P Giorgi-Rossi, F Carozzi, M Confortini… - The lancet …, 2010 - thelancet.com
Background Human papillomavirus (HPV) testing is known to be more sensitive, but less
specific than cytology for detecting cervical intraepithelial neoplasia (CIN). We assessed the …

Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older …

PE Castle, MH Stoler, TC Wright, A Sharma… - The lancet …, 2011 - thelancet.com
Background The ATHENA study was designed to assess the performance of carcinogenic
human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping compared with liquid …

The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV …

MJ Khan, PE Castle, AT Lorincz… - Journal of the …, 2005 - academic.oup.com
Background: Human papillomavirus (HPV) types 16 and 18 cause 60%–70% of cervical
cancer worldwide, and other HPV types cause virtually all remaining cases. Pooled HPV …

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

CJLM Meijer, J Berkhof, PE Castle… - … journal of cancer, 2009 - Wiley Online Library
Given the strong etiologic link between high‐risk HPV infection and cervical cancer high‐risk
HPV testing is now being considered as an alternative for cytology‐based cervical cancer …

Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice

HA Katki, WK Kinney, B Fetterman, T Lorey… - The lancet …, 2011 - thelancet.com
Background Concurrent testing for human papillomavirus (HPV) and cervical cytology (co-
testing) is an approved alternative to cytology alone in women aged 30 years and older. We …

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

J Dillner, M Rebolj, P Birembaut, KU Petry, A Szarewski… - Bmj, 2008 - bmj.com
Objective To obtain large scale and generalisable data on the long term predictive value of
cytology and human papillomavirus (HPV) testing for development of cervical intraepithelial …

Human papillomavirus and Papanicolaou tests to screen for cervical cancer

P Naucler, W Ryd, S Törnberg, A Strand… - … England Journal of …, 2007 - Mass Medical Soc
Background Screening for cervical cancer based on testing for human papillomavirus (HPV)
increases the sensitivity of detection of high-grade (grade 2 or 3) cervical intraepithelial …